New Mexico treats patients using Varian RapidArc

The New Mexico Cancer Center in Albuquerque is using RapidArc from Varian Medical Systems to deliver stereotactic radiotherapy to patients.

Stereotactic radiotherapy utilizing RapidArc technology enables doctors to target metastatic brain tumors faster and more accurately than was possible with earlier treatment technologies, according to Bryan Goss, MD, a radiation oncologist at the center.

The New Mexico Cancer Center has also used RapidArc radiotherapy to treat prostate cancer with image-guided radiotherapy with a 90-second treatment time, the Palo Alto, Calif.-based Varian said.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.